Literature DB >> 8508031

p53 domains: suppression, transformation, and transactivation.

M Reed1, Y Wang, G Mayr, M E Anderson, J F Schwedes, P Tegtmeyer.   

Abstract

We investigated the suppression, transformation, and transactivation functions of isolated segments of wild-type murine p53. Intact p53, but no segment of p53, inhibited cellular transformation by the activated ras and adenovirus E1A proteins. We conclude that most of p53 is needed for suppression of cellular proliferation. Nevertheless, the transactivating domain of herpesvirus protein VP16 was able to substitute for the N-terminal transactivating domain of p53 in cellular suppression. Thus, unless the interchanged p53 and VP16 acidic segments share additional functions, transactivation is required for suppression by p53. Interestingly, we found that all p53 segments containing amino acids 320-360 enhanced transformation by ras and E1A. This region has been associated with the oligomerization of p53 (Milner et al., 1991; Sturzbecher et al., 1992). Furthermore, no p53 segment lacking amino acids 320-360 transformed cells. Amino acids 320-360, therefore, may account for the major transforming activity of p53. Intact p53 and chimeric VP16-p53 transactivated the CAT gene under control of a p53-specific promoter, while transforming segments of p53 interfered with transactivation by wild-type p53. Our findings argue that transactivation by p53 is required for cellular suppression and that any nontransactivating p53 that retains the capacity to oligomerize with wild-type p53 would have transformation potential.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8508031      PMCID: PMC6081624     

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  62 in total

1.  Genetic mechanisms of tumor suppression by the human p53 gene.

Authors:  P L Chen; Y M Chen; R Bookstein; W H Lee
Journal:  Science       Date:  1990-12-14       Impact factor: 47.728

2.  Formation of stable p53 homotetramers and multiples of tetramers.

Authors:  J E Stenger; G A Mayr; K Mann; P Tegtmeyer
Journal:  Mol Carcinog       Date:  1992       Impact factor: 4.784

3.  Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene.

Authors:  L Raycroft; H Y Wu; G Lozano
Journal:  Science       Date:  1990-08-31       Impact factor: 47.728

4.  Meth A fibrosarcoma cells express two transforming mutant p53 species.

Authors:  D Eliyahu; N Goldfinger; O Pinhasi-Kimhi; G Shaulsky; Y Skurnik; N Arai; V Rotter; M Oren
Journal:  Oncogene       Date:  1988-09       Impact factor: 9.867

Review 5.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

6.  Amplification of a gene encoding a p53-associated protein in human sarcomas.

Authors:  J D Oliner; K W Kinzler; P S Meltzer; D L George; B Vogelstein
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

7.  Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.

Authors:  W E Mercer; M T Shields; M Amin; G J Sauve; E Appella; J W Romano; S J Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

8.  Analysis of p53 mutants for transcriptional activity.

Authors:  L Raycroft; J R Schmidt; K Yoas; M M Hao; G Lozano
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

9.  Wild-type p53 binds to the TATA-binding protein and represses transcription.

Authors:  E Seto; A Usheva; G P Zambetti; J Momand; N Horikoshi; R Weinmann; A J Levine; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

10.  Monoclonal antibodies specific for the carboxy terminus of simian virus 40 large T antigen.

Authors:  H MacArthur; G Walter
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

View more
  18 in total

1.  Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains.

Authors:  V S Ossovskaya; I A Mazo; M V Chernov; O B Chernova; Z Strezoska; R Kondratov; G R Stark; P M Chumakov; A V Gudkov
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

2.  p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells.

Authors:  O Eizenberg; A Faber-Elman; E Gottlieb; M Oren; V Rotter; M Schwartz
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

3.  Reciprocal interference between the sequence-specific core and nonspecific C-terminal DNA binding domains of p53: implications for regulation.

Authors:  M E Anderson; B Woelker; M Reed; P Wang; P Tegtmeyer
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

4.  The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation.

Authors:  M Reed; B Woelker; P Wang; Y Wang; M E Anderson; P Tegtmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

5.  Epstein-Barr virus nuclear protein 2A forms oligomers in vitro and in vivo through a region required for B-cell transformation.

Authors:  S Tsui; W H Schubach
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

6.  p53 expression during normal tissue regeneration in response to acute cutaneous injury in swine.

Authors:  H N Antoniades; T Galanopoulos; J Neville-Golden; C P Kiritsy; S E Lynch
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

7.  Interaction of p53 with its consensus DNA-binding site.

Authors:  Y Wang; J F Schwedes; D Parks; K Mann; P Tegtmeyer
Journal:  Mol Cell Biol       Date:  1995-04       Impact factor: 4.272

8.  Sequence-specific transcriptional activation is essential for growth suppression by p53.

Authors:  J A Pietenpol; T Tokino; S Thiagalingam; W S el-Deiry; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

9.  p53 domains: structure, oligomerization, and transformation.

Authors:  P Wang; M Reed; Y Wang; G Mayr; J E Stenger; M E Anderson; J F Schwedes; P Tegtmeyer
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

10.  Molecular analysis of p53 gene in laryngeal premalignant and malignant lesions. p53 protein immunohistochemical expression is positively related to proliferating cell nuclear antigen labelling index.

Authors:  V Gorgoulis; V Zoumpourlis; G Rassidakis; A Karameris; C Barbatis; D A Spandidos; C Kittas
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.